BSX Boston Scientific Loading...

From MDT earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
13:00
Feb 17 ◎
Jeff Head of 911 Solutions, Axon Enterprise, Inc. MDT Q3 FY26 call
Medtronic's renal denervation (Simplicity) direct-to-consumer website visits jumped from 50,000 to 2.5 million quarter-over-quarter, indicating significant patient demand and market development traction. — This early consumer demand signal suggests the RDN market could develop faster than expected, benefiting Medtronic and pressuring competitors like Boston Scientific.
BSX
MED

About BSX Analyst Coverage

Buzzberg tracks BSX (Boston Scientific) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Jeff.